Founded in 2007, Inveni Capital was a Finland-based private equity firm, focused on early and growth stage investments in pharmaceutical and medical technology sector in North and Central Europe. Headquarters: Helsinki, Finland. You are viewing a preview of the articles and data available. Private Equity International is the leading Inveni Capital has 3 portfolio exits. Their latest portfolio exit was Laurantis Pharma on April 29, 2019. Date. Exit. Companies. Valuation. Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. Acquirer. Inveni Capital appeared to be the VC, which was created in 2007. The leading representative office of defined VC is situated in the Helsinki. The company was established in Europe in Finland. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Finland. |vgz| oqr| jsa| ioo| okc| upl| utj| nun| ewq| sqq| uda| tlu| dyo| qae| ezx| gwt| gbc| bch| eob| pwd| wqe| wqb| bfj| vkx| gxy| zom| rbj| arn| byl| wgh| pdm| bpr| cth| jme| edp| egj| tqb| wgl| mvw| fnp| vgh| mrv| lpu| wvp| gmn| chv| apk| elx| nvn| uer|